Neoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate Cancer

Clinical trial NCT05917860 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05917860
Sponsor: Turku University Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Localized Prostate Carcinoma Castration-Naive Prostate Cancer Intermediate Risk Prostate Cancer Prostate Cancer

Start date: 2023-07-18
Primary completion: 2026-01-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.